BDX · Becton Dickinson & Co · Executive Compensation
$177.85
+1.43 (+0.81%)
At close · Sep 11
Market Cap
$48.31B
Shares
272.39M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael D. Garrison | Executive Vice President and President of the Medical Essentials and BioPharma Systems segments | Retired | 2026-07-22 |
| Michael D. Garrison | Executive Vice President and President of the Medical Essentials and BioPharma Systems segments | Retired | 2026-07-22 |
| Claire M. Fraser, Ph.D. | Waters Corporation Board of Directors | Appointed | 2026-02-09 |
| Claire M. Fraser, Ph.D. | director of the Company | Resigned | 2026-02-09 |
| Jacqueline Wright | Board of Directors | Appointed | 2025-11-17 |
| Robert L. Huffines | Board of Directors | Appointed | 2025-11-17 |
| Christopher J. DelOrefice | Executive Vice President and Chief Financial Officer | Resigned | 2025-10-15 |
| Gregory J. Hayes | Board of Directors | Appointed | 2025-03-27 |
| Pamela L. Spikner | Senior Vice President, Chief Accounting Officer and Controller | Appointed | 2025-01-10 |
| Christopher DelOrefice | principal accounting officer | Appointed | 2024-08-30 |
| Thomas Spoerel | principal accounting officer | Resigned | 2024-08-30 |
| Thomas Spoerel | Senior Vice President, CFO Regions | Appointed | 2024-08-30 |
Key facts
CIK
10795
CUSIP
075887109
13F (30d)
393 filings
366 filers
Visit website
Investor relations